You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1306 Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus: association with N-Methyl-D- aspartate receptor NR2 subunit and cytokines

Article Text

Article menu

Download PDFPDF

Pediatrics
1306 Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus: association with N-Methyl-D- aspartate receptor NR2 subunit and cytokines
  1. Samara Rosa Sepresse1,2,
  2. Ana Carolina Londe Capelli Alencar1,
  3. Jaqueline Cristina de Amorim1,2,
  4. Taís Nitsch Mazzola3,
  5. Mariana Moraes da Silva Lucino1,2,
  6. Roberto Marini5 and
  7. Simone Appenzeller1,4,5
  1. 1Autoimmunity Laboratory, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
  2. 2Postgraduate Program in Child and Adolescent Health, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
  3. 3Center for Investigation in Pediatrics, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
  4. 4Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
  5. 5Rheumatology Unit, Department of Orthopedics, Rheumatology and Traumatology, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil

Abstract

Background Childhood-onset systemic lupus erythematosus (cSLE) is an autoimmune disease, which causes systemic involvement, including within the central nervous system (CNS). Since biomarkers for neuropsychiatric manifestations (NPM) are still an incognita, the aim of this study was to assess whether serum levels of the NR-2 subunit of the N-methyl-D-aspartate glutamate receptor and cytokines were associated with NPM in patients with cSLE.

Methods Patients diagnosed with cSLE were included at this cross-sectional study. NPM were evaluated according to the American College of Rheumatology (ACR) classification. Assessment of cognitive impairment was performed using Automated Neuropsychological Assessment Metrics (ANAM) and Montreal Cognitive Assessment (MoCA). Anxiety and depression symptoms were assessed using the Beck Anxiety Inventory (BAI) and Beck’s Depression Inventory (BDI), respectively. Serum levels of NR-2 were evaluated by ELISA, while serum levels of IL-4, IL-6, IL-10, IL-12, TNF and IFN-γ were measured by Luminex.

Results 155 patients were included, divided into three groups: recent NPM (with NPM at the blood collection), previous NPM (without NPM during the time of blood collection, however with previous NPM) and absent NPM (without the presence of NPM at any time since the diagnosis of cSLE). The most observed NPM were anxiety (70.9%), depression (47.3%), cognitive impairment (30.9%) and headache (5.5%). Serum NR-2 levels did not differ between groups. Serum concentrations of IL-10 (11.2 x 7.0pg/ml, p= 0.040), IL-12 (3.5 x 2.0pg/ml, p=0.002,), IFN-γ (12.2 x 8.9 pg/mL, p=0.003) and TNF (8.8 x 6.2 pg/mL, p=0.029) were higher in the recent MNP group when compared to the absent MNP group. Furthermore, higher serum concentrations of IL-12 were observed in patients with anxiety (3.5 x 2.9pg/mL, p=0.035), IL-4 (36.0 x 70.8pg/mL, p=0.036) and IL-6 (1.7 x 4.4pg/mL, p=0.019) in patients without cognitive impairment and NR-2 in patients with depression (9.9 x 8.5ng/mL, p=0.032). Patients with cognitive disorders had lower percentages of correct answers in the ANAM subtests, in addition to the highest score in the performance validity index, characteristic of the cognitive disorder (p<0.001).

Conclusion Th1 serum cytokines were associated to cSLE patients with CNS involvement. Furthermore, IL-12 and NR-2 can be considered possible serum biomarkers for anxiety and depression in cSLE.

  • cSLE
  • NR-2
  • Th2 and Th1 cytokines
  • ANAM
  • cognitive dysfunction.
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/lupus-2023-lupus21century.94

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.